TMJ Disorders Market Research Report: Information By Type (Myofacial Pain, Internal Derangement, and Arthritis), By Treatment (Medication, Therapies, and Surgical Treatment), By End-User (Hospitals & Clinics, Ambulatory Surgery Center, Research, and Academic Institutes), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 14

1.1.1 MARKET SYNOPSIS 14

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 15

2.2 RESEARCH OBJECTIVE 15

2.3 LIST OF ASSUMPTIONS & LIMITATIONS 15

3 RESEARCH METHODOLOGY

3.1.1 OVERVIEW 17

3.2 DATA MINING 17

3.3 SECONDARY RESEARCH 18

3.4 PRIMARY RESEARCH 19

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 20

3.5 FORECASTING TECHNIQUES 20

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21

3.6.1 BOTTOM-UP APPROACH 22

3.6.2 TOP-DOWN APPROACH 23

3.7 DATA TRIANGULATION 23

3.8 VALIDATION 23

4 MARKET DYNAMICS

4.1 OVERVIEW 24

4.2 DRIVERS 25

4.2.1 INCREASING PREVALENCE OF TMJ DISORDERS 25

4.2.2 TECHNOLOGICAL ADVANCEMENTS IN TREATMENT OPTION FOR TMJ DISORDERS 25

4.2.3 RISING NUMBER OF CLINICAL TRIALS 25

4.2.4 GOVERNMENT SUPPORT IN FAVOR OF TMJ DISORDERS 26

4.3 RESTRAINTS 27

4.3.1 POORLY UNDERSTOOD ETIOLOGY OF TMJ DISORDER 27

4.4 OPPORTUNITIES 27

4.4.1 RISING DEMAND FOR NON-INVASIVE TREATMENT MODALITIES FOR TMJ 27

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS 28

5.1.1 R&D AND DESIGNING 29

5.1.2 MANUFACTURING 29

5.1.3 DISTRIBUTION & SALES 29

5.1.4 POST-SALES MONITORING 29

5.2 PORTER’S FIVE FORCES MODEL 30

5.2.1 BARGAINING POWER OF SUPPLIERS 30

5.2.2 BARGAINING POWER OF BUYERS 31

5.2.3 THREAT OF NEW ENTRANTS 31

5.2.4 THREAT OF SUBSTITUTES 31

5.2.5 RIVALRY 31

5.3 COVID-19 IMPACT ANALYSIS 32

5.3.1 IMPACT ON SUPPLY CHAIN 32

5.3.2 IMPACT ON DENTAL PRACTICES 32

5.3.3 IMPACT ON REGION 32

5.3.4 IMPACT ON PATIENT VISITS 33

5.4 US EPIDEMIOLOGY DATA 33

6 GLOBAL TMJ DISORDERS MARKET, BY TYPE

6.1 OVERVIEW 34

6.2 MYOFASCIAL PAIN 35

6.3 INTERNAL DERANGEMENT 36

6.4 ARTHRITIS 36

7 GLOBAL TMJ DISORDERS MARKET, BY TREATMENT

7.1 OVERVIEW 37

7.2 MEDICATION 38

7.3 THERAPIES 39

7.4 SURGICAL TREATMENT 39

8 GLOBAL TMJ DISORDERS MARKET, BY END USER

8.1 OVERVIEW 40

8.2 HOSPITALS & CLINICS 41

8.3 AMBULATORY SURGERY CENTER 41

8.4 RESEARCH AND ACADEMIC INSTITUTES 42

9 GLOBAL TMJ DISORDERS MARKET, BY REGION

9.1 OVERVIEW 43

9.2 AMERICAS 44

9.2.1 NORTH AMERICA 46

9.2.1.1 US 48

9.2.1.2 CANADA 49

9.2.2 LATIN AMERICA 50

9.3 EUROPE 52

9.3.1 WESTERN EUROPE 54

9.3.1.1 GERMANY 56

9.3.1.2 FRANCE 58

9.3.1.3 UK 59

9.3.1.4 ITALY 60

9.3.1.5 SPAIN 62

9.3.1.6 REST OF WESTERN EUROPE 63

9.3.2 EASTERN EUROPE 64

9.4 ASIA-PACIFIC 66

9.4.1 CHINA 68

9.4.2 JAPAN 69

9.4.3 INDIA 71

9.4.4 AUSTRALIA 72

9.4.5 SOUTH KOREA 73

9.4.6 REST OF ASIA-PACIFIC 75

9.5 MIDDLE EAST & AFRICA 77

9.5.1 MIDDLE EAST 79

9.5.2 AFRICA 80

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW 82

10.2 GLOBAL TMJ DISORDERS COMPANY RANKING ANALYSIS (2023) 82

10.3 COMPETITIVE BENCHMARKING 83

10.3.1 AGREEMENT 84

10.3.2 ACQUISITION 84

10.3.3 EXPANSION 84

10.3.4 LAUNCH & APPROVAL 84

11 COMPANY PROFILE

11.1 ABBOTT LABORATORIES 85

11.1.1 COMPANY OVERVIEW 85

11.1.2 FINANCIAL OVERVIEW 86

11.1.3 PRODUCTS/SERVICES OFFERED 86

11.1.4 KEY DEVELOPMENTS 86

11.1.5 SWOT ANALYSIS 87

11.1.6 KEY STRATEGIES 87

11.2 SUN PHARMACEUTICAL INDUSTRIES LIMITED 88

11.2.1 COMPANY OVERVIEW 88

11.2.2 FINANCIAL OVERVIEW 89

11.2.3 PRODUCTS/SERVICES OFFERED 89

11.2.4 KEY DEVELOPMENTS 90

11.2.5 SWOT ANALYSIS 90

11.2.6 KEY STRATEGIES 90

11.3 BRISTOL-MYERS SQUIBB COMPANY 91

11.3.1 COMPANY OVERVIEW 91

11.3.2 FINANCIAL OVERVIEW 91

11.3.3 PRODUCTS/SERVICES OFFERED 92

11.3.4 KEY DEVELOPMENTS 92

11.3.5 SWOT ANALYSIS 92

11.3.6 KEY STRATEGIES 92

11.4 TEVA PHARMACEUTICAL INDUSTRIES LTD 93

11.4.1 COMPANY OVERVIEW 93

11.4.2 FINANCIAL OVERVIEW 93

11.4.3 PRODUCTS/SERVICES OFFERED 94

11.4.4 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS 94

11.4.5 SWOT ANALYSIS 94

11.4.6 KEY STRATEGIES 94

11.5 ALLERGAN 95

11.5.1 COMPANY OVERVIEW 95

11.5.2 FINANCIAL OVERVIEW 95

11.5.3 PRODUCTS/SERVICES OFFERED 96

11.5.4 ALLERGAN: KEY DEVELOPMENTS 96

11.5.5 SWOT ANALYSIS 97

11.5.6 KEY STRATEGIES 97

11.6 BAYER AG 98

11.6.1 COMPANY OVERVIEW 98

11.6.2 FINANCIAL OVERVIEW 98

11.6.3 PRODUCTS/SERVICES OFFERED 99

11.6.4 KEY DEVELOPMENTS 99

11.6.5 SWOT ANALYSIS 99

11.6.6 KEY STRATEGIES 99

11.7 ZYDUS CADILA 100

11.7.1 COMPANY OVERVIEW 100

11.7.2 FINANCIAL OVERVIEW 100

11.7.3 PRODUCTS/SERVICES OFFERED 101

11.7.4 KEY DEVELOPMENTS 101

11.7.5 SWOT ANALYSIS 101

11.7.6 KEY STRATEGIES 101

11.8 MYLAN NV 102

11.8.1 COMPANY OVERVIEW 102

11.8.2 FINANCIAL OVERVIEW 102

11.8.3 PRODUCTS/SERVICES OFFERED 103

11.8.4 KEY DEVELOPMENTS 103

11.8.5 SWOT ANALYSIS 103

11.8.6 KEY STRATEGIES 104

11.9 NOVARTIS INTERNATIONAL AG 105

11.9.1 COMPANY OVERVIEW 105

11.9.2 FINANCIAL OVERVIEW 106

11.9.3 PRODUCTS/SERVICES OFFERED 106

11.9.4 KEY DEVELOPMENTS 106

11.9.5 SWOT ANALYSIS 106

11.9.6 KEY STRATEGIES 107

11.10 JUBILANT LIFE SCIENCES LIMITED 108

11.10.1 COMPANY OVERVIEW 108

11.10.2 FINANCIAL OVERVIEW 109

11.10.3 PRODUCTS/SERVICES OFFERED 109

11.10.4 KEY DEVELOPMENTS 109

11.10.5 SWOT ANALYSIS 110

11.10.6 KEY STRATEGIES 110

12 APPENDIX

12.1 RELATED REPORTS 111

13 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 15

TABLE 2 US EPIDEMIOLOGY DATA 33

TABLE 3 GLOBAL TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 35

TABLE 4 GLOBAL TMJ DISORDERS MARKET, FOR MYOFASCIAL PAIN, BY REGION, 2023-2030 (USD MILLION) 35

TABLE 5 GLOBAL TMJ DISORDERS MARKET, FOR INTERNAL DERANGEMENT, BY REGION, 2023-2030 (USD MILLION) 36

TABLE 6 GLOBAL TMJ DISORDERS MARKET, FOR ARTHRITIS, BY REGION, 2023-2030 (USD MILLION) 36

TABLE 7 GLOBAL TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 38

TABLE 8 GLOBAL TMJ DISORDERS MARKET, FOR MEDICATION, BY REGION, 2023-2030 (USD MILLION) 38

TABLE 9 GLOBAL TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 39

TABLE 10 GLOBAL TMJ DISORDERS MARKET, FOR THERAPY, BY REGION, 2023-2030 (USD MILLION) 39

TABLE 11 GLOBAL TMJ DISORDERS MARKET, FOR SURGICAL TREATMENT, BY REGION, 2023-2030 (USD MILLION) 39

TABLE 12 GLOBAL TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 41

TABLE 13 GLOBAL TMJ DISORDERS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2023-2030 (USD MILLION) 41

TABLE 14 GLOBAL TMJ DISORDERS MARKET, FOR AMBULATORY SURGERY CENTER, BY REGION, 2023-2030 (USD MILLION) 41

TABLE 15 GLOBAL TMJ DISORDERS MARKET, FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION) 42

TABLE 16 GLOBAL TMJ DISORDERS MARKET, BY REGION, 2023-2030 (USD MILLION) 43

TABLE 17 AMERICAS: TMJ DISORDERS MARKET, BY REGION, 2023-2030 (USD MILLION) 44

TABLE 18 AMERICAS: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 44

TABLE 19 AMERICAS: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 45

TABLE 20 AMERICAS: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 45

TABLE 21 AMERICAS: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 45

TABLE 22 NORTH AMERICA: TMJ DISORDERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 46

TABLE 23 NORTH AMERICA: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 46

TABLE 24 NORTH AMERICA: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 47

TABLE 25 NORTH AMERICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 47

TABLE 26 NORTH AMERICA: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 47

TABLE 27 US: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 48

TABLE 28 US: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 48

TABLE 29 US: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 48

TABLE 30 US: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 49

TABLE 31 CANADA: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 49

TABLE 32 CANADA: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 49

TABLE 33 CANADA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 50

TABLE 34 CANADA: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 50

TABLE 35 LATIN AMERICA: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 50

TABLE 36 LATIN AMERICA: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 51

TABLE 37 LATIN AMERICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 51

TABLE 38 LATIN AMERICA: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 51

TABLE 39 EUROPE: TMJ DISORDERS MARKET, BY REGION, 2023-2030 (USD MILLION) 52

TABLE 40 EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 53

TABLE 41 EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 53

TABLE 42 EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 53

TABLE 43 EUROPE: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 54

TABLE 44 WESTERN EUROPE: TMJ DISORDERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 55

TABLE 45 WESTERN EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 55

TABLE 46 WESTERN EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 55

TABLE 47 WESTERN EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 56

TABLE 48 WESTERN EUROPE: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 56

TABLE 49 GERMANY: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 56

TABLE 50 GERMANY: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 57

TABLE 51 GERMANY: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 57

TABLE 52 GERMANY: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 57

TABLE 53 FRANCE: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 58

TABLE 54 FRANCE: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 58

TABLE 55 FRANCE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 58

TABLE 56 FRANCE: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 59

TABLE 57 UK: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 59

TABLE 58 UK: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 59

TABLE 59 UK: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 60

TABLE 60 UK: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 60

TABLE 61 ITALY: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 60

TABLE 62 ITALY: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 61

TABLE 63 ITALY: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 61

TABLE 64 ITALY: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 61

TABLE 65 SPAIN: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 62

TABLE 66 SPAIN: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 62

TABLE 67 SPAIN: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 62

TABLE 68 SPAIN: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 63

TABLE 69 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 63

TABLE 70 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 63

TABLE 71 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 64

TABLE 72 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 64

TABLE 73 EASTERN EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 64

TABLE 74 EASTERN EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 65

TABLE 75 EASTERN EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 65

TABLE 76 EASTERN EUROPE: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 65

TABLE 77 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 66

TABLE 78 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 67

TABLE 79 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 67

TABLE 80 ASIA-PACIFIC: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 67

TABLE 81 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 68

TABLE 82 CHINA: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 68

TABLE 83 CHINA: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 68

TABLE 84 CHINA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 69

TABLE 85 CHINA: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 69

TABLE 86 JAPAN: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 69

TABLE 87 JAPAN: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 70

TABLE 88 JAPAN: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 70

TABLE 89 JAPAN: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 70

TABLE 90 INDIA: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 71

TABLE 91 INDIA: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 71

TABLE 92 INDIA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 71

TABLE 93 INDIA: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 72

TABLE 94 AUSTRALIA: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 72

TABLE 95 AUSTRALIA: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 72

TABLE 96 AUSTRALIA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 73

TABLE 97 AUSTRALIA: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 73

TABLE 98 SOUTH KOREA: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 73

TABLE 99 SOUTH KOREA: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 74

TABLE 100 SOUTH KOREA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 74

TABLE 101 SOUTH KOREA: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 74

TABLE 102 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 75

TABLE 103 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 75

TABLE 104 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 75

TABLE 105 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 76

TABLE 106 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY REGION, 2023-2030 (USD MILLION) 77

TABLE 107 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 77

TABLE 108 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 78

TABLE 109 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 78

TABLE 110 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 78

TABLE 111 MIDDLE EAST: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 79

TABLE 112 MIDDLE EAST: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 79

TABLE 113 MIDDLE EAST: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 79

TABLE 114 MIDDLE EAST: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 80

TABLE 115 AFRICA: TMJ DISORDERS MARKET, BY TYPE, 2023-2030 (USD MILLION) 80

TABLE 116 AFRICA: TMJ DISORDERS MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 80

TABLE 117 AFRICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 81

TABLE 118 AFRICA: TMJ DISORDERS MARKET, BY END USER, 2023-2030 (USD MILLION) 81

TABLE 119 GLOBAL TMJ DISORDERS COMPANY RANKING ANALYSIS (2023) 82

TABLE 120 AGREEMENT 84

TABLE 121 ACQUISITION 84

TABLE 122 EXPANSION 84

TABLE 123 LAUNCH & APPROVAL 84

TABLE 124 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 86

TABLE 125 SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCTS/SERVICES OFFERED 89

TABLE 126 BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS/SERVICES OFFERED 92

TABLE 127 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS/SERVICES OFFERED 94

TABLE 128 ALLERGAN: PRODUCTS/SERVICES OFFERED 96

TABLE 129 ALLERGAN: KEY DEVELOPMENTS 96

TABLE 130 BAYER AG.: PRODUCTS/SERVICES OFFERED 99

TABLE 131 ZYDUS CADILA: PRODUCTS/SERVICES OFFERED 101

TABLE 132 MYLAN NV: PRODUCTS/SERVICES OFFERED 103

TABLE 133 MYLAN NV: KEY DEVELOPMENTS 103

TABLE 134 NOVARTIS INTERNATIONAL AG: PRODUCTS/SERVICES OFFERED 106

TABLE 135 JUBILANT LIFE SCIENCES LIMITED: PRODUCTS/SERVICES OFFERED 109

14 LIST OF FIGURES

FIGURE 1 GLOBAL TMJ DISORDERS MARKET STRUCTURE 16

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 22

FIGURE 3 MARKET DYNAMICS: GLOBAL TMJ DISORDERS MARKET 24

FIGURE 4 DRIVERS: IMPACT ANALYSIS 26

FIGURE 5 RESTRAINTS: IMPACT ANALYSIS 27

FIGURE 6 VALUE CHAIN: TMJ DISORDERS MARKET 28

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: TMJ DISORDERS MARKET 30

FIGURE 8 GLOBAL TMJ DISORDERS MARKET, BY TYPE, 2023 AND 2030 (USD MILLION) 35

FIGURE 9 GLOBAL TMJ DISORDERS MARKET, BY TREATMENT, 2023 AND 2030 (USD MILLION) 38

FIGURE 10 GLOBAL TMJ DISORDERS MARKET, BY END USER, 2023 AND 2030 (USD MILLION) 40

FIGURE 11 GLOBAL TMJ DISORDERS MARKET, BY REGION, 2023 AND 2030 (USD MILLION) 43

FIGURE 12 AMERICAS: TMJ DISORDERS MARKET, BY REGION, 2023 AND 2030 (USD MILLION) 44

FIGURE 13 NORTH AMERICA: TMJ DISORDERS MARKET, BY COUNTRY, 2023 AND 2030 (USD MILLION) 46

FIGURE 14 EUROPE: TMJ DISORDERS MARKET, BY REGION, 2023 AND 2030 (USD MILLION) 52

FIGURE 15 WESTERN EUROPE: TMJ DISORDERS MARKET, BY COUNTRY, 2023 AND 2030 (USD MILLION) 54

FIGURE 16 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY COUNTRY, 2023 AND 2030 (USD MILLION) 66

FIGURE 17 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY REGION, 2023 AND 2030 (USD MILLION) 77

FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS 83

FIGURE 19 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 86

FIGURE 20 ABBOTT LABORATORIES: SWOT ANALYSIS 87

FIGURE 21 SUN PHARMACEUTICAL INDUSTRIES LIMITED: FINANCIAL OVERVIEW SNAPSHOT 89

FIGURE 22 SUN PHARMACEUTICAL INDUSTRIES LIMITED: SWOT ANALYSIS 90

FIGURE 23 BRISTOL-MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW 91

FIGURE 24 BRISTOL-MYERS SQUIBB COMPANY: SWOT ANALYSIS 92

FIGURE 25 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT 93

FIGURE 26 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS 94

FIGURE 27 ALLERGAN: FINANCIAL OVERVIEW SNAPSHOT 95

FIGURE 28 ALLERGAN: SWOT ANALYSIS 97

FIGURE 29 BAYER AG.: FINANCIAL OVERVIEW SNAPSHOT 98

FIGURE 30 BAYER AG.: SWOT ANALYSIS 99

FIGURE 31 ZYDUS CADILA: FINANCIAL OVERVIEW SNAPSHOT 100

FIGURE 32 ZYDUS CADILA: SWOT ANALYSIS 101

FIGURE 33 MYLAN NV: FINANCIAL OVERVIEW SNAPSHOT 102

FIGURE 34 MYLAN NV: SWOT ANALYSIS 103

FIGURE 35 NOVARTIS INTERNATIONAL AG: FINANCIAL OVERVIEW SNAPSHOT 106

FIGURE 36 NOVARTIS INTERNATIONAL AG: SWOT ANALYSIS 106

FIGURE 37 JUBILANT LIFE SCIENCES LIMITED: FINANCIAL OVERVIEW SNAPSHOT 109

FIGURE 38 JUBILANT LIFE SCIENCES LIMITED: SWOT ANALYSIS 110